Train Babcock Advisors LLC cut its stake in shares of Centene Corporation (NYSE:CNC) by 36.6% during the 4th quarter, HoldingsChannel reports. The firm owned 36,139 shares of the company’s stock after selling 20,891 shares during the quarter. Centene accounts for about 1.6% of Train Babcock Advisors LLC’s holdings, making the stock its 24th largest position. Train Babcock Advisors LLC’s holdings in Centene were worth $3,645,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Mckinley Capital Management LLC Delaware purchased a new position in Centene during the second quarter valued at $101,000. Baldwin Brothers Inc. MA purchased a new position in Centene during the third quarter valued at $185,000. Sii Investments Inc. WI purchased a new position in Centene during the second quarter valued at $202,000. Calamos Advisors LLC purchased a new position in Centene during the third quarter valued at $207,000. Finally, Commerzbank Aktiengesellschaft FI purchased a new position in Centene during the third quarter valued at $207,000. Institutional investors own 91.84% of the company’s stock.
Shares of Centene Corporation (CNC) traded up $1.05 during trading on Wednesday, hitting $105.97. The stock had a trading volume of 1,085,100 shares, compared to its average volume of 1,196,983. Centene Corporation has a fifty-two week low of $61.03 and a fifty-two week high of $106.74. The stock has a market capitalization of $18,140.00, a P/E ratio of 21.89, a price-to-earnings-growth ratio of 1.32 and a beta of 0.70. The company has a quick ratio of 0.99, a current ratio of 0.99 and a debt-to-equity ratio of 0.71.
Several equities analysts recently weighed in on the company. Leerink Swann reiterated a “market perform” rating and set a $90.00 target price (up from $78.00) on shares of Centene in a research report on Wednesday, September 13th. Cowen reiterated an “outperform” rating and set a $105.00 target price (up from $77.00) on shares of Centene in a research report on Wednesday, September 13th. Piper Jaffray Companies reiterated a “buy” rating and set a $134.00 target price on shares of Centene in a research report on Monday, December 18th. Jefferies Group lifted their target price on Centene from $112.00 to $115.00 and gave the company a “buy” rating in a research report on Monday, December 18th. Finally, Goldman Sachs Group assumed coverage on Centene in a research report on Wednesday, January 3rd. They set a “buy” rating and a $135.00 target price on the stock. One analyst has rated the stock with a sell rating, three have assigned a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $104.21.
In related news, EVP Keith H. Williamson sold 5,000 shares of the business’s stock in a transaction dated Tuesday, January 2nd. The stock was sold at an average price of $100.11, for a total value of $500,550.00. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Robert K. Ditmore sold 8,750 shares of the business’s stock in a transaction dated Monday, January 8th. The stock was sold at an average price of $104.30, for a total value of $912,625.00. The disclosure for this sale can be found here. Insiders sold 27,917 shares of company stock worth $2,777,255 over the last quarter. 3.00% of the stock is owned by company insiders.
Centene Corporation is a healthcare company. The Company provides a portfolio of services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. The Company operates through two segments: Managed Care and Specialty Services. The Company’s Managed Care segment provides health plan coverage to individuals, through government subsidized programs, including Medicaid, the State Children’s Health Insurance Program (CHIP), Long Term Care, Foster Care, dual-eligible individuals (Duals) and the Supplemental Security Income Program, also known as the Aged, Blind or Disabled Program (ABD), Medicare, and Health Insurance Marketplace.
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Corporation (NYSE:CNC).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.